Myriad Genetics Reports - Industry Research
Reports Featuring Myriad Genetics
Global Pancreatic Cancer Therapeutics and Diagnostics Market
The Global Pancreatic Cancer Therapeutics and Diagnostics Market size is estimated at USD 4.56 billion in 2024, and is expected to reach USD 6.55 billion by 2029, growing at a CAGR of 7.52% during the forecast period (2024-2029).
Clinical Laboratory Services Market
The Clinical Laboratory Services Market size is estimated at USD 277.96 billion in 2024, and is expected to reach USD 380.65 billion by 2029, growing at a CAGR of 6.49% during the forecast period (2024-2029).
Genomics Market
The genomics market is expected to register a CAGR of nearly 15.89% during the forecast period, with a revenue of approximately USD 19.5 billion during the base year, and it is expected to reach USD 47 billion over the forecast period.
Global Preventive Healthcare Technologies and Services Market
The Global Preventive Healthcare Technologies and Services Market size is estimated at USD 325.74 billion in 2024, and is expected to reach USD 590.76 billion by 2029, growing at a CAGR of 12.64% during the forecast period (2024-2029).
Asia-Pacific Genetic Testing Market
The Asia-Pacific Genetic Testing Market size is estimated at USD 4.35 billion in 2024, and is expected to reach USD 7.63 billion by 2029, growing at a CAGR of 11.90% during the forecast period (2024-2029).
United States Esoteric Testing Market
The United States Esoteric Testing Market size is estimated at USD 8.53 billion in 2024, and is expected to reach USD 11.79 billion by 2029, growing at a CAGR of 6.70% during the forecast period (2024-2029).
Predictive and Presymptomatic Testing Market
The predictive and presymptomatic testing market is poised to grow at a CAGR of 8.4% over the forecast period.
Cancer Biopsies Market
The Cancer Biopsies Market size is estimated at USD 29.93 billion in 2024, and is expected to reach USD 51.48 billion by 2029, growing at a CAGR of 11.46% during the forecast period (2024-2029).
Genomic Biomarkers Market
The global genomic biomarkers market is expected to witness a CAGR of 9.2% over the forecast period.
Global Clinical Oncology NGS Market
The Clinical Oncology NGS Market is expected to grow at the registered CAGR of 16.9% during the forecast period, 2022-2027.
North America Breast Cancer Screening Tests Market
The North America Breast Cancer Screening Tests Market size is expected to grow from USD 1.16 billion in 2023 to USD 1.74 billion by 2028, at a CAGR of 8.44% during the forecast period (2023-2028).
Europe Breast Cancer Screening Tests Market
The Europe Breast Cancer Screening Tests Market size is estimated at USD 0.83 billion in 2024, and is expected to reach USD 1.26 billion by 2029, growing at a CAGR of 8.68% during the forecast period (2024-2029).
Other Reports Covering Myriad Genetics
Medical Devices
- Asia-Pacific Genetic Testing Market
- Autoimmune Disease Diagnostics Market
- Breast Cancer Liquid Biopsy Market
- Cancer Biopsies Market
- Cancer Diagnostics Market
- Carrier Screening Market
- Companion Diagnostics Market
- Europe Autoimmune Disease Diagnostics Market
- Europe Breast Cancer Screening Tests Market
- Europe Genetic Testing Market
- Europe Molecular Diagnostics Market
- Genetic Testing Market
- Genomic Biomarkers Market
- Global Biomarkers Market
- Global Breast Cancer Screening Test Market
- Molecular Diagnostics Market
- North America Autoimmune Disease Diagnostics Market
- North America Breast Cancer Screening Tests Market
- North America Molecular Diagnostics Market
- Predictive and Presymptomatic Testing Market
- United States Esoteric Testing Market
- Women's Health Diagnostics Market
